OpenAI CEO Altman Accused of Turning Parenthood Into a Business With His Partner Through For-Profit Surrogacy
Critics accused Sam Altman and his partner of commercialising parenthood through surrogacy

OpenAI CEO Sam Altman was celebrating the arrival of his first child when his baby announcement became the centre of a fierce online fight over surrogacy.
Altman and his partner, Oliver Mulherin, welcomed a baby boy in February 2025, with Altman sharing a photo of the newborn and writing, 'Welcome to the world, little guy!'
But critics quickly accused the couple of effectively 'buying' a baby and argued that for-profit surrogacy should be banned.
Altman Welcomed His First Child Through Surrogacy
Altman announced the birth on X, describing the experience in deeply emotional terms and writing, 'I have never felt such love.' The newborn was reportedly in a neonatal intensive care unit at the time, while Altman received messages of congratulations from prominent figures, including Microsoft CEO Satya Nadella.
The announcement also brought immediate criticism. Some commentators focused on the use of a surrogate, arguing that separating a newborn from the woman who carried the pregnancy raises difficult questions about motherhood and the commercialisation of reproduction.
One particularly hostile reaction described Altman and Mulherin as having 'purchased a baby' and claimed that gay couples should not be permitted to 'buy children'.
The language quickly pushed the discussion beyond the mechanics of surrogacy and into a broader argument about same-sex parenthood.
OpenAI CEO Sam Altman and his gay partner purchased a baby boy through surrogacy and showcased him on social media, despite having just separated him from his mother.
— Anna Lulis (@annamlulis) September 15, 2026
Gay couples should not be allowed to buy children. pic.twitter.com/FjOb8jyCcs
Critics Say Commercial Surrogacy Turns Babies Into Products
Critics argue that wealthy intended parents may have an advantage in a system where surrogates can receive financial compensation.
They say the arrangement can create an uncomfortable imbalance between people who can afford fertility services and women who may be motivated by financial circumstances.
Those concerns are not entirely hypothetical. Questions about exploitation, informed consent and the treatment of surrogates have long surrounded the international surrogacy industry, particularly in jurisdictions where legal safeguards are weak.
For Altman, however, there is no evidence in the supplied accounts that his own surrogacy arrangement involved coercion or wrongdoing.
Fertility Lawyer Pushes Back Against Online Claims
Fertility lawyer Lisa Feldstein strongly challenged the reaction to Altman's announcement, arguing that the online debate was filled with misconceptions about how surrogacy works.
In a February 2025 commentary, Feldstein said surrogacy can be a 'voluntary, altruistic, and deeply meaningful experience'. She pointed to Canada and parts of the US as examples of systems where legal and medical safeguards can protect surrogates and intended parents.
Feldstein acknowledged that exploitation can occur, particularly where women have limited legal protection or financial vulnerability. However, she argued that such cases should not be used to portray every surrogacy arrangement as inherently unethical.
She also suggested that some of the hostility directed at Altman appeared to reflect discomfort with LGBTQ+ families rather than genuine concerns about reproductive ethics.
Altman Backlash Opens a Bigger Surrogacy Debate
Opponents want greater restrictions on commercial surrogacy and argue that financial transactions should not determine access to parenthood.
Supporters counter that carefully regulated arrangements can allow people who cannot have children naturally to build families while giving surrogates meaningful control over their own decisions.
The debate is particularly complicated because surrogacy can involve money, medicine, consent, genetics and deeply personal questions about parenthood all at once.
© Copyright IBTimes 2026. All rights reserved.




















